Homocysteine metabolism and risk of myocardial infarction: Relation with vitamins B6, B12, and folate

American Journal of Epidemiology

Volumn 143, Issue 9, 1996, Pages 845-859

  Verhoef, Petra ^a   Stampfer, Meir J ^b,c,f   Buring, Julie E ^b   Gaziano, J Michael ^b   Allen, Robert H ^d   Stabler, Sally P ^d   Reynolds, Robert D ^e   Kok, Frans J ^a   Hennekens, Charles H ^b,c   Willett, Walter C ^b,c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f CHANNING LABORATORY   (United States)

Author keywords

Folic acid; Homocysteine; Myocardial infarction; Pyridoxine; Vitamin B 12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

CASE-CONTROL STUDIES; DIET; DIET SURVEYS; FASTING; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; MALE; METHIONINE; METHYLATION; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PYRIDOXINE; RISK FACTORS; VITAMIN B 12;

EID: 0029924647     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008828     Document Type: Article

References (37)

1. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-501.
2. Rees MM, Rodgers GM. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993;71:337-59.
3. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992;55:131-8.
4. 6, and folate on blood homocysteine levels. Ann N Y Acad Sci 1992;30:197-204.
5. Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In: Francis RBJ, ed. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker, Inc, 1992:183-236.
6. Malinow MR. Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis. Circulation 1990;81:2004-6.
7. Malinow MR. Homocyst(e)ine and arterial occlusive disease: a mini review. Clin Chem 1994;40:173-6.
8. Stampfer MJ, Malinow MR, Willett WC. et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-81.
9. Amesen E, Refsum H, Bønaa KH, et al. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995;24: 704-9.
10. Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
11. 6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993;57:47-53.
12. Brattström LE, Israelsson B, Jeppsson JO, et al. Folic acid: an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1988;48:215-21.
13. Ubbink JB, van der Merwe A, Vermaak WJH, et al. Hyperhomocysteinemia and the response to vitamin supplementation. Clin Investig 1993;71:993-8.
14. 12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 1994;59:940-8.
15. 12) and folate deficiency. FASEB J 1993;7:1344-53.
16. Buring JE, O'Connor GT, Goldhaber SZ, et al. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation 1992;85: 22-9.
17. Paffenbarger RS Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978;108:161-75.
18. 6 analysis. In: Pesce AJ, Kaplan LA, eds. Methods in clinical chemistry. St. Louis, MO: CV Mosby, 1987:558-68.
19. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65.
20. Willett WC, Sampson L, Browne ML, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988;127:188-99.
21. Colditz GA, Willett WC, Stampfer MJ, et al. The influence of age, relative weight, smoking, and alcohol intake on the reproducibility of a dietary questionnaire. Int J Epidemiol 1987; 16:392-8.
22. Willett WC. Nutritional epidemiology. New York: Oxford University Press, 1989.
23. US Department of Agriculture. Composition of foods: raw, processed, prepared. Washington. DC: US GPO, 1963-1988. (USDA handbook no. 8 series).
24. Willen W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
25. Brattström L, Israelsson B, Norrving B. et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Atherosclerosis 1990;81:51-60.
26. 6: its role in health and disease. New York: Alan R Liss, Inc, 1985:337-46.
27. Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Adaptation to methionine excess. J Biol Chem 1986; 261:1582-7.
28. Israelsson B, Brattström LE, Hultberg BL. Homocysteine and myocardial infarction. Atherosclerosis 1988;71:227-33.
29. Malinow MR, Sexton G, Averbuch M, et al. Homocyst(e)ine in daily practice: levels in coronary artery disease. Coron Artery Dis 1990;1:215-20.
30. Ubbink JB, Vermaak WHJ, Bennett JM, et al. The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr 1991;69:527-34.
31. Genest JJ Jr, McNamara JR, Salem DN, et al. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990;16:1114-19.
32. Kang SS, Wong PW, Cook HY, et al. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. J Clin Invest 1986;77:1482-6.
33. Von Eckardstein A. Malinow MR, Upson B, et al. Effects of age, lipoproteine, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men. Arterioscler Thromb 1994;14:460-4.
34. 6, pyridoxal phosphate, and folate. Am J Cardiol 1995;75:1107-11.
35. McCully KS. Chemical pathology of homocysteine. I. Atherogenesis. Ann Clin Lab Sei 1993;23:477-93.
36. Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A 1994;91: 6369-73.
37. Stampfer MJ, Willett WC. Homocysteine and marginal vitamin deficiency. The importance of adequate vitamin intake. (Editorial). JAMA 1993;270:2726-7.